Service des maladies infectieuses

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


2447 publications

... | 2022 | 2021 | ...
Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors.
Royo-Cebrecos C., Laporte-Amargós J., Peña M., Ruiz-Camps I., Puerta-Alcalde P., Abdala E., Oltolini C., Akova M., Montejo M., Mikulska M. et al., 2022/09/30. Pathogens, 11 (10) p. 1132. Peer-reviewed.
 
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.
Chaudron S.E., Leemann C., Kusejko K., Nguyen H., Tschumi N., Marzel A., Huber M., Böni J., Perreau M., Klimkait T. et al., 2022/09/28. The Journal of infectious diseases, 226 (7) pp. 1256-1266. Peer-reviewed.
 
Prevalence and Factors Associated with Prosthetic Joint Infections in Patients with Staphylococcus aureus Bacteraemia: A 7-Year Retrospective Study.
Papadimitriou-Olivgeris M., Senn L., Bertelli C., Grandbastien B., Steinmetz S., Boillat-Blanco N., 2022/09/28. Antibiotics, 11 (10) p. 1323. Peer-reviewed.
 
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Jakeman B., Scherrer A.U., Darling KEA, Damas J., Bieler-Aeschlimann M., Hasse B., Schlosser L., Hachfeld A., Gutbrod K., Tarr P.E. et al., 2022/09. Open forum infectious diseases, 9 (9) pp. ofac457. Peer-reviewed.
Immunocompromised patients have been neglected in COVID-19 trials: a call for action.
Trøseid M., Hentzien M., Ader F., Cardoso S.W., Arribas J.R., Molina J.M., Mueller N., Hites M., Bonnet F., Manuel O. et al., 2022/09. Clinical microbiology and infection, 28 (9) pp. 1182-1183. Peer-reviewed.
 
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Hirzel C., Projer L., Atkinson A., Surial B., Mueller N.J., Manuel O., Mombelli M., van Delden C., Hirsch H.H., Boggian K. et al., 2022/09/01. Transplantation, 106 (9) pp. 1875-1883. Peer-reviewed.
 
Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.
Tejada S., Martinez-Reviejo R., Karakoc H.N., Peña-López Y., Manuel O., Rello J., 2022/09. Advances in therapy, 39 (9) pp. 4037-4051. Peer-reviewed.
 
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.
Lamoth F., Lewis R.E., Kontoyiannis D.P., 2022/08/31. Clinical infectious diseases, 75 (3) pp. 534-544. Peer-reviewed.
 
High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies.
Tschopp J., Brunel A.S., Spertini O., Croxatto A., Lamoth F., Bochud P.Y., 2022/08/25. Clinical infectious diseases, 75 (2) pp. 330-333. Peer-reviewed.
 
Acute abdomen with haemorrhagic shock while cruising on a private sailboat in the Atlantic Ocean.
Potin M., Calmes J.M., De Vallière S., 2022/08/20. Journal of travel medicine, 29 (5) pp. taac062. Peer-reviewed.
A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits.
Nadeau S., Thorball C.W., Kouyos R., Günthard H.F., Böni J., Yerly S., Perreau M., Klimkait T., Rauch A., Hirsch H.H. et al., 2022/08/03. Molecular biology and evolution, 39 (8) pp. msac163. Peer-reviewed.
A first update on mapping the human genetic architecture of COVID-19
Pathak G. A., Polimanti R., Karjalainen J., Daly M., Ganna A., Daly M. J., Stevens C., Kanai M., Liao R. G., Trankiem A. et al., 2022/08. Nature, 608 (7921) pp. E1-E10. Peer-reviewed.
 
Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.
Kampouri E., Filippidis P., Wölfle M., Taveira A., Badinski T., Croxatto A., Galperine T., Grandbastien B., Achermann Y., Guery B., 2022/08. Infectious diseases now, 52 (5) pp. 267-272. Peer-reviewed.
 
Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
Girardin F., Manuel O., Marzolini C., Buclin T., 2022/08. Clinical microbiology and infection, 28 (8) pp. 1044-1046. Peer-reviewed.
 
SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
Jacot D., von Rotz U., Blondet F., Aebischer O., Matthieu P., De Rham M., Pantaleo G., Marchetti O., Greub G., 2022/08. Journal of medical microbiology, 71 (8). Peer-reviewed.
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.
Kusejko K., Tschumi N., Chaudron S.E., Nguyen H., Battegay M., Bernasconi E., Böni J., Huber M., Calmy A., Cavassini M. et al., 2022/08/01. Journal of acquired immune deficiency syndromes, 90 (4) pp. e4-e12. Peer-reviewed.
Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review.
Martinez-Reviejo R., Tejada S., Cipriano A., Karakoc H.N., Manuel O., Rello J., 2022/08. Anaesthesia, critical care & pain medicine, 41 (4) p. 101098. Peer-reviewed.
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
Papadimitriou-Olivgeris M., Battistolo J., Poissy J., Coste A., Bochud P.Y., Calandra T., Senn L., Lamoth F., 2022/08. Open forum infectious diseases, 9 (8) pp. ofac383. Peer-reviewed.
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
Thoueille P., Alves Saldanha S., Schaller F., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B., Furrer H. et al., 2022/07/29. Pharmaceutics, 14 (8) p. 1588. Peer-reviewed.
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
Interactions between Medical Plant-Derived Bioactive Compounds: Focus on Antimicrobial Combination Effects.
Vaou N., Stavropoulou E., Voidarou C.C., Tsakris Z., Rozos G., Tsigalou C., Bezirtzoglou E., 2022/07/28. Antibiotics, 11 (8) p. 1014. Peer-reviewed.
 
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
Bick A.G., Popadin K., Thorball C.W., Uddin M.M., Zanni M.V., Yu B., Cavassini M., Rauch A., Tarr P., Schmid P. et al., 2022/07/08. Scientific reports, 12 (1) p. 11638. Peer-reviewed.
 
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H., Hampel B., Nuñez D.G., Battegay M., Hachfeld A., Bernasconi E., Calmy A., Cavassini M., Vernazza P., Fellay J. et al., 2022/07/06. Clinical infectious diseases, 74 (12) p. 2266. Peer-reviewed.
Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients.
Dos Santos Q., Wareham N.E., Mocroft A., Rasmussen A., Gustafsson F., Perch M., Sørensen S.S., Manuel O., Müller N.J., Lundgren J. et al., 2022/07/04. Cancers, 14 (13) p. 3279. Peer-reviewed.
Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.
Munoz O., Banga R., Schelling R., Procopio F.A., Mastrangelo A., Nortier P., Ohmiti K., Daraspe J., Cavassini M., Fenwick C. et al., 2022/07. PLoS pathogens, 18 (7) pp. e1010673. Peer-reviewed.
Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study.
van den Bogaart L., Lang B.M., Rossi S., Neofytos D., Walti L.N., Khanna N., Mueller N.J., Boggian K., Garzoni C., Mombelli M. et al., 2022/07. The Journal of infection, 85 (1) pp. 1-7. Peer-reviewed.
 
Fecal microbiota transplantation: a review on current formulations in Clostridioides difficile infection and future outlooks.
Rakotonirina A., Galperine T., Allémann E., 2022/07. Expert opinion on biological therapy, 22 (7) pp. 929-944. Peer-reviewed.
Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes.
Brune J.E., Dickenmann M., Wehmeier C., Sidler D., Walti L., Golshayan D., Manuel O., Hadaya K., Neofytos D., Schnyder A. et al., 2022/07. American journal of transplantation, 22 (7) pp. 1823-1833. Peer-reviewed.
Implementing a surgical site infection prevention bundle for emergency appendectomy: Worth the effort or waste of time?
Jurt J., Floquet L., Hübner M., Moulin E., Senn L., Demartines N., Grass F., 2022/07. Surgery, 172 (1) pp. 11-15. Peer-reviewed.
 
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
Mocroft A., Miro J.M., Wandeler G., Llibre J.M., Boyd A., van Bremen K., Beniowski M., Mikhalik J., Cavassini M., Maltez F. et al., 2022/07. HIV medicine, 23 (6) pp. 585-598. Peer-reviewed.
Ultrasound for point-of-care sputum-free tuberculosis detection: Building collaborative standardized image-banks.
Suttels V., Wachinou P., Toit J.D., Boillat-Blanco N., Hartley M.A., 2022/07. EBioMedicine, 81 p. 104078. Peer-reviewed.
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study.
Filippidis P., Kampouri E., Woelfle M., Badinski T., Croxatto A., Galperine T., Papadimitriou-Olivgeris M., Grandbastien B., Achermann Y., Guery B., 2022/06/30. Journal of clinical medicine, 11 (13) p. 3805. Peer-reviewed.
Utility of Polymerase Chain Reaction in Nasopharyngeal Swabs for Identifying Respiratory Bacteria Causing Community-Acquired Pneumonia.
Demars Y., Brahier T., Rotzinger D.C., Brouillet R., Jaton K., Opota O., Boillat-Blanco N., 2022/06/29. Microbiology spectrum, 10 (3) pp. e0037922. Peer-reviewed.
Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center.
Schaad S., Brahier T., Hartley M.A., Cordonnier J.B., Bosso L., Espejo T., Pantet O., Hugli O., Carron P.N., Meuwly J.Y. et al., 2022/06/24. BMJ open, 12 (6) pp. e060181. Peer-reviewed.
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.
Winter B.L., Hovaguimian F., Kouyos R.D., Schmidt A.J., Bernasconi E., Braun D.L., Calmy A., Notter J., Stoeckle M., Surial B. et al., 2022/06/20. Swiss medical weekly, 152 pp. w30192. Peer-reviewed.
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial.
Karakike E., Scicluna B.P., Roumpoutsou M., Mitrou I., Karampela N., Karageorgos A., Psaroulis K., Massa E., Pitsoulis A., Chaloulis P. et al., 2022/06/18. Critical care, 26 (1) p. 183. Peer-reviewed.
 
Impact of Latent Tuberculosis on Diabetes.
Tepekule B., Kusejko K., Zeeb M., Tarr P.E., Calmy A., Battegay M., Furrer H., Cavassini M., Bernasconi E., Notter J. et al., 2022/06/15. The Journal of infectious diseases, 225 (12) pp. 2229-2234. Peer-reviewed.
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Born T., Aruanno M., Kampouri E., Mombelli M., Monney P., Tozzi P., Lamoth F., 2022/06. Mycopathologia, 187 (2-3) pp. 249-258. Peer-reviewed.
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study.
Trickey A., Zhang L., Gill M.J., Bonnet F., Burkholder G., Castagna A., Cavassini M., Cichon P., Crane H., Domingo P. et al., 2022/06. The lancet. HIV, 9 (6) pp. e404-e413. Peer-reviewed.
 
Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E. et al., 2022/06. Journal of general internal medicine, 37 (8) pp. 1943-1952. Peer-reviewed.
 
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).
Cesaro S., Ljungman P., Mikulska M., Hirsch H.H., von Lilienfeld-Toal M., Cordonnier C., Meylan S., Mehra V., Styczynski J., Marchesi F. et al., 2022/06. Leukemia, 36 (6) pp. 1467-1480. Peer-reviewed.
 
The unresolved issues in the management of mucormycosis.
Lamoth F., 2022/06. European journal of internal medicine, 100 pp. 29-30. Peer-reviewed.
 
Correction to: Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).
Cornely O.A., Gachot B., Akan H., Bassetti M., Uzun O., Kibbler C., Marchetti O., de Burghgraeve P., Ramadan S., Pylkkanen L. et al., 2022/05/30. Clinical infectious diseases, 74 (10) p. 1892. Peer-reviewed.
 
SER-109 for Recurrent Clostridioides difficile Infection.
Benech N., Galperine T., Sokol H., French Group of Fecal Microbiota Transplantation, 2022/05/19. The New England journal of medicine, 386 (20) pp. 1956-1957. Peer-reviewed.
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
Prescription des antibiotiques guidée par les biomarqueurs en médecine de famille : CRP ou PCT ? [Biomarker-guided antibiotics prescription for lower respiratory tract infections in primary care : CRP or PCT ?]
Vingerhoets S., Mueller Y., Pedrazzini B., Boillat-Blanco N., Lhopitallier L., 2022/05/11. Revue medicale suisse, 18 (781) pp. 948-952. Peer-reviewed.
Assessment of SARS-CoV-2 tests costs and reimbursement tariffs readjustments during the COVID-19 pandemic.
Caruana G., Brouillet R., Opota O., Greub G., 2022/05/09. Swiss medical weekly, 152 pp. w30168. Peer-reviewed.
 
Point prevalence study of antibiotic appropriateness and possibility of early discharge from hospital among patients treated with antibiotics in a Swiss University Hospital.
Moulin E., Boillat-Blanco N., Zanetti G., Plüss-Suard C., de Vallière S., Senn L., 2022/05/07. Antimicrobial resistance and infection control, 11 (1) p. 66. Peer-reviewed.
 
Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study.
Balakrishna S., Wolfensberger A., Kachalov V., Roth J.A., Kusejko K., Scherrer A.U., Furrer H., Hauser C., Calmy A., Cavassini M. et al., 2022/05/04. The Journal of infectious diseases, 225 (9) pp. 1592-1600. Peer-reviewed.
 
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years.
Schoepf I.C., Thorball C.W., Ledergerber B., Kootstra N.A., Reiss P., Raffenberg M., Engel T., Braun D.L., Hasse B., Thurnheer C. et al., 2022/05/04. The Journal of infectious diseases, 225 (9) pp. 1581-1591. Peer-reviewed.
Vaccins de voyage : quel horizon ? [Travel vaccines: what is in the pipeline?]
Miauton A., De Vallière S., Genton B., 2022/05/04. Revue medicale suisse, 18 (780) pp. 890-893. Peer-reviewed.
Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.
van den Bogaart L., Manuel O., 2022/05/02. Antibiotics, 11 (5) p. 612. Peer-reviewed.
 
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
Maschmeyer G., Bullinger L., Garcia-Vidal C., Herbrecht R., Maertens J., Menna P., Pagano L., Thiebaut-Bertrand A., Calandra T., 2022/05. Leukemia, 36 (5) p. 1450. Peer-reviewed.
Discussing Challenges in Diagnosis of Tuberculous Meningitis and Neurosarcoidosis.
Santos A., Desgranges F., Jovanovic M., Anichini A., Kritikos A., Dunet V., Brouland J.P., Théaudin M., Pot C., Du Pasquier R. et al., 2022/05. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 49 (3) pp. 445-451. Peer-reviewed.
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
Maschmeyer G., Bullinger L., Garcia-Vidal C., Herbrecht R., Maertens J., Menna P., Pagano L., Thiebaut-Bertrand A., Calandra T., 2022/05. Leukemia, 36 (5) pp. 1215-1226. Peer-reviewed.
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
Lazor-Blanchet C., Zygoura P., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Grandbastien B., Fenwick C., Pantaleo G. et al., 2022/05. The Journal of infection, 84 (5) pp. 722-746. Peer-reviewed.
 
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review.
Filippidis P., Vionnet J., Manuel O., Mombelli M., 2022/05. Expert review of anti-infective therapy, 20 (5) pp. 663-680. Peer-reviewed.
 
Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H., Hampel B., Garcia Nuñez D., Battegay M., Hachfeld A., Bernasconi E., Calmy A., Cavassini M., Vernazza P., Fellay J. et al., 2022/04/28. Clinical infectious diseases, 74 (8) pp. 1468-1475. Peer-reviewed.
Nouveaux antibiotiques ? Perspectives
Guery B., 2022/04/27. Revue medicale suisse, 18 (779) pp. 837-838. Peer-reviewed.
Prise en charge du papillomavirus humain au cabinet médical : que faire pour les hommes ? [Management of human papillomavirus at the doctor's office : what to do for men ?]
Ebstein D., Vu F., Bodenmann P., De Vallière S., 2022/04/20. Revue medicale suisse, 18 (778) pp. 770-773. Peer-reviewed.
 
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2022/04/19. Antimicrobial agents and chemotherapy, 66 (4) pp. e0006722. Peer-reviewed.
Antibiothérapies lors d’infections courantes de la sphère ORL [Antibiotics use for common ENT infections]
Kratz B., Boillat Blanco N., Tschopp J., 2022/04/13. Revue medicale suisse, 18 (777) pp. 694-699. Peer-reviewed.
Bas les masques, et après ?
Kaiser L., Vetter P., Calmy A., Manuel O., Calandra T., 2022/04/13. Revue medicale suisse, 18 (777) pp. 691-692. Peer-reviewed.
Staphylococcus aureus résistant à la méticilline : 15 ans de surveillance moléculaire en Suisse romande [Methicillin-resistant Staphylococcus aureus: 15 years of molecular epidemiology in Western Switzerland]
Blanc D.S., Grandbastien B., Bally F., Lienhard R., Tritten M.L., Clerc O., Fracheboud D., Pfister S., Chuard C., Burr M. et al., 2022/04/13. Revue medicale suisse, 18 (777) pp. 724-728. Peer-reviewed.
Tularémie pulmonaire : un diagnostic à ne pas manquer [Pulmonary tularemia : a diagnosis not to be missed]
Uriel Valladares P., Opota O., Beigelman-Aubry C., Bochud P.Y., Lamoth F., 2022/04/13. Revue medicale suisse, 18 (777) pp. 707-711. Peer-reviewed.
An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters.
Salazar-Vizcaya L., Kusejko K., Günthard H.F., Böni J., Metzner K.J., Braun D.L., Nicca D., Bernasconi E., Calmy A., Darling KEA et al., 2022/04/10. Viruses, 14 (4) p. 784. Peer-reviewed.
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J., Heinonen T., Fenwick C., Schrijver I.T., Ohmiti K., Moradpour D., Cavassini M., Pantaleo G., Roger T., Calandra T. et al., 2022/04. Clinical microbiology and infection, 28 (4) pp. 611.e1-611.e7. Peer-reviewed.
 
Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital.
Munting A., Regina J., Damas J., Lhopitallier L., Kritikos A., Guery B., Senn L., Viala B., 2022/04. Clinical microbiology and infection, 28 (4) pp. 558-563. Peer-reviewed.
 
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians.
Lamoth F., 2022/04/01. Current opinion in infectious diseases, 35 (2) pp. 163-169. Peer-reviewed.
 
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians.
Kampouri E., Walti C.S., Gauthier J., Hill J.A., 2022/04. Expert review of hematology, 15 (4) pp. 305-320. Peer-reviewed.
Stapled Porcine Pericardium Displays Lower Infectivity In Vitro Than Native and Sutured Porcine Pericardium.
Del Tatto B., Le Roy D., Lambelet M., Corpataux J.M., Chakfé N., Giulieri S., Allagnat F., Roger T., Saucy F., 2022/04. The Journal of surgical research, 272 pp. 132-138. Peer-reviewed.
Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
Suttels V., André P., Thoma Y., Veuve F., Decosterd L., Guery B., Buclin T., 2022/04. JAC-antimicrobial resistance, 4 (2) pp. dlac043. Peer-reviewed.
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).
Hachfeld A., Atkinson A., Stute P., Calmy A., Tarr P.E., Darling K., Babouee Flury B., Polli C., Sultan-Beyer L., Abela I.A. et al., 2022/04. HIV medicine, 23 (4) pp. 417-425. Peer-reviewed.
 
Cardiovascular risk assessment in people living with HIV compared to the general population.
Delabays B., Cavassini M., Damas J., Beuret H., Calmy A., Hasse B., Bucher H.C., Frischknecht M., Müller O., Méan M. et al., 2022/03/30. European journal of preventive cardiology, 29 (4) pp. 689-699. Peer-reviewed.
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
Albasanz-Puig A., Durà-Miralles X., Laporte-Amargós J., Mussetti A., Ruiz-Camps I., Puerta-Alcalde P., Abdala E., Oltolini C., Akova M., Montejo J.M. et al., 2022/03/29. Microorganisms, 10 (4) p. 733. Peer-reviewed.
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
Veloza L., Tsai C.Y., Bisig B., Pantet O., Alberio L., Sempoux C., Cavassini M., de Leval L., 2022/03. Virchows Archiv, 480 (3) pp. 699-705. Peer-reviewed.
HIV testing in termination of pregnancy and colposcopy services: a scoping review.
Filippidis P., Francini K., Jacot-Guillarmod M., Mathevet P., Lhopitallier L., Cavassini M., Darling KEA, 2022/03. Sexually transmitted infections, 98 (2) pp. 143-149. Peer-reviewed.
 
MRSA surveillance programmes worldwide: moving towards a harmonised international approach.
Baede V.O., David M.Z., Andrasevic A.T., Blanc D.S., Borg M., Brennan G., Catry B., Chabaud A., Empel J., Enger H. et al., 2022/03. International journal of antimicrobial agents, 59 (3) p. 106538. Peer-reviewed.
Unexpected associations between respiratory viruses and bacteria with Pulmonary Function Testing in children suffering from Cystic Fibrosis (MUCOVIB study).
Scherz V., Caruana G., Taffé P., Brouillet R., Bertelli C., Jaton K., Fougère Y., Posfay-Barbe K.M., Mornand A., Rochat-Guignard I. et al., 2022/03. Journal of cystic fibrosis, 21 (2) pp. e158-e164. Peer-reviewed.
 
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).
Scherrer A.U., Traytel A., Braun D.L., Calmy A., Battegay M., Cavassini M., Furrer H., Schmid P., Bernasconi E., Stoeckle M. et al., 2022/02/18. International journal of epidemiology, 51 (1) pp. 33-34j. Peer-reviewed.
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure.
Schrijver I.T., Karakike E., Théroude C., Baumgartner P., Harari A., Giamarellos-Bourboulis E.J., Calandra T., Roger T., 2022/02/11. Intensive care medicine experimental, 10 (1) p. 5. Peer-reviewed.
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytes.
Pronier E., Imanci A., Selimoglu-Buet D., Badaoui B., Itzykson R., Roger T., Jego C., Naimo A., Francillette M., Breckler M. et al., 2022/02/03. Communications biology, 5 (1) p. 110. Peer-reviewed.
 
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.
Jakeman B., Scherrer A., Battegay M., Gunthard H.F., Hachfeld A., Calmy A., Schmid P., Bernasconi E., Cavassini M., Marzolini C., 2022/02/02. The Journal of antimicrobial chemotherapy, 77 (2) pp. 492-499. Peer-reviewed.
Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.
Dao K., Fuchs A., André P., Giannoni E., Decosterd L.A., Marchetti O., Asner S.A., Pfister M., Widmer N., Buclin T. et al., 2022/02/02. The Journal of antimicrobial chemotherapy, 77 (2) pp. 457-465. Peer-reviewed.
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection.
Thoueille P., Choong E., Cavassini M., Buclin T., Decosterd L.A., 2022/02/02. The Journal of antimicrobial chemotherapy, 77 (2) pp. 290-302. Peer-reviewed.
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.
Ragozzino S., Goldenberger D., Wright P.R., Zimmerli S., Mühlethaler K., Neofytos D., Riat A., Boggian K., Nolte O., Conen A. et al., 2022/02. Open forum infectious diseases, 9 (2) pp. ofab638. Peer-reviewed.
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
Roth R.S., Masouridi-Levrat S., Giannotti F., Mamez A.C., Glambedakis E., Lamoth F., Bochud P.Y., Erard V., Emonet S., Van Delden C. et al., 2022/02. Mycoses, 65 (2) pp. 199-210. Peer-reviewed.
Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
Hovaguimian F., Martin E., Reinacher M., Rasi M., Schmidt A.J., Bernasconi E., Boffi El Amari E., Braun D.L., Calmy A., Darling K. et al., 2022/02. HIV medicine, 23 (2) pp. 146-158. Peer-reviewed.
Reply to: 'Lack of evidence for intergenerational inheritance of immune resistance to infections'.
Katzmarski N., Domínguez-Andrés J., Cirovic B., Renieris G., Ciarlo E., Le Roy D., Lepikhov K., Kattler K., Gasparoni G., Händler K. et al., 2022/02. Nature immunology, 23 (2) pp. 208-209. Peer-reviewed.
 
Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study.
Duran Ramirez J.J., Ballouz T., Nguyen H., Kusejko K., Chaudron S.E., Huber M., Hirsch H.H., Perreau M., Ramette A., Yerly S. et al., 2022/01/18. The Journal of infectious diseases, 225 (2) pp. 306-316. Peer-reviewed.
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
Bick A.G., Popadin K., Thorball C.W., Uddin M.M., Zanni M.V., Yu B., Cavassini M., Rauch A., Tarr P., Schmid P. et al., 2022/01/12. Scientific reports, 12 (1) p. 577. Peer-reviewed.
Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania.
Hogendoorn SKL, Lhopitallier L., Richard-Greenblatt M., Tenisch E., Mbarack Z., Samaka J., Mlaganile T., Mamin A., Genton B., Kaiser L. et al., 2022/01/06. BMC infectious diseases, 22 (1) p. 39. Peer-reviewed.
 
Case report: Disseminated Scedosporium apiospermum infection with invasive right atrial mass in a heart transplant patient.
Bourlond B., Cipriano A., Regamey J., Papadimitriou-Olivgeris M., Kamani C., Seidel D., Lamoth F., Muller O., Yerly P., 2022. Frontiers in cardiovascular medicine, 9 p. 1045353. Peer-reviewed.
Clonal dissemination and resistance genes among Stenotrophomonas maltophilia in a Greek University Hospital during a four-year period.
Papadimitriou-Olivgeris M., Kolonitsiou F., Militsopoulou M., Spiliopoulou I., Giormezis N., 2022. AIMS microbiology, 8 (3) pp. 292-299. Peer-reviewed.
Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS).
Hachfeld A., Atkinson A., Calmy A., de Tejada B.M., Hasse B., Paioni P., Kahlert C.R., Boillat-Blanco N., Stoeckle M., Aebi-Popp K. et al., 2022/01. HIV medicine, 23 (1) pp. 60-69. Peer-reviewed.
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
van den Bogaart L., Lang B.M., Neofytos D., Egli A., Walti L.N., Boggian K., Garzoni C., Berger C., Pascual M., van Delden C. et al., 2022/01. American journal of transplantation, 22 (1) pp. 199-209. Peer-reviewed.
 
How to Manage Pseudomonas aeruginosa Infections
Papadimitriou-Olivgeris Matthaios, Jacot Damien, Guery Benoit, 2022. pp. 425-445 dans Pseudomonas aeruginosa, Springer International Publishing.
How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
Pellaton N., Sanglard D., Lamoth F., Coste A.T., 2022. Frontiers in cellular and infection microbiology, 12 p. 859439. Peer-reviewed.
 
Hépatite B chez les patients migrants
Jaboyedoff Manon, Genton Blaise, Masserey Éric, Bodenmann Patrick, Rimaz Roland, De Vallière Serge, 2022. pp. 507-515 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 3.5, RMS éditions / Médecine et Hygiène.
 
Increased incidence of candidemia in critically ill patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
Papadimitriou-Olivgeris M., Kolonitsiou F., Kefala S., Spiliopoulou A., Aretha D., Bartzavali C., Siapika A., Marangos M., Fligou F., 2022. The Brazilian journal of infectious diseases, 26 (2) p. 102353. Peer-reviewed.
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
Stehlin F., Mahdi-Aljedani R., Canton L., Monzambani-Banderet V., Miauton A., Girard C., Kammermann K., Meylan S., Ribi C., Harr T. et al., 2022. Frontiers in allergy, 3 p. 818049. Peer-reviewed.
 
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
Roth R.S., Masouridi-Levrat S., Chalandon Y., Mamez A.C., Giannotti F., Riat A., Fischer A., Poncet A., Glampedakis E., Van Delden C. et al., 2022/01. Open forum infectious diseases, 9 (1) pp. ofab596. Peer-reviewed.
Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series.
Halfon M., Stavart L., Venetz J.P., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10716. Peer-reviewed.
 
Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection.
Begré L., Béguelin C., Boyd A., Peters L., Rockstroh J., Günthard H.F., Bernasconi E., Cavassini M., Lacombe K., Mocroft A. et al., 2022. Frontiers in medicine, 9 p. 988356. Peer-reviewed.
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study.
Iuliano S., Senn L., Moi L., Muller Y.D., Ribi C., Buss G., Comte D., 2022. Frontiers in allergy, 3 p. 853587. Peer-reviewed.
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
Bandiera C., Pasquier J., Locatelli I., Niquille A., Wuerzner G., Dotta-Celio J., Hachfeld A., Wandeler G., Wagner A.D., Csajka C. et al., 2022. Patient preference and adherence, 16 pp. 2313-2320. Peer-reviewed.
Modes of action and diagnostic value of miRNAs in sepsis.
Antonakos N., Gilbert C., Théroude C., Schrijver I.T., Roger T., 2022. Frontiers in immunology, 13 p. 951798. Peer-reviewed.
Molecular typing of Clostridioides difficile from frozen stool samples to investigate cross-transmissions: A proof of concept.
Blanc D.S., Poncet F., Grandbastien B., Prod'hom G., Greub G., Senn L., 2022. Indian journal of medical microbiology, 40 (4) pp. 531-535. Peer-reviewed.
 
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Papadimitriou-Olivgeris M., Cipriano A., Guggisberg N., Kroemer M., Tschopp J., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10721. Peer-reviewed.
Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
Pache B., Balaya V., Mathis J., Hübner M., Sahli R., Cavassini M., Sempoux C., Mathevet P., Jacot-Guillarmod M., 2022. PloS one, 17 (10) pp. e0276438. Peer-reviewed.
 
Prise en charge de maladies infectieuses auprès des requérants d’asile et détenus vaudois
Chastonay Oriane, Masserey Éric, Dory Élodie, Beaupere Pascale, Mazza-Stalder Jesica, De Vallière Serge, L'hostis Yann, Bodenmann Patrick, 2022. pp. 493-505 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 3.4, RMS éditions / Médecine et Hygiène.
 
Promotion de la vaccination antigrippale durant la visite médicale d'embauche
Currat Michael, Lazor-Blanchet Catherine, Zanetti Giorgio, 2022. dans Congrès national de médecine et santé au travail, 14-17 juin 2022, Strasbourg, France.
The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection.
Noto A., Suffiotti M., Joo V., Mancarella A., Procopio F.A., Cavet G., Leung Y., Corpataux J.M., Cavassini M., Riva A. et al., 2022. Frontiers in immunology, 13 p. 960120. Peer-reviewed.
 
The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia.
Papadimitriou-Olivgeris M., Monney P., Mueller L., Senn L., Guery B., 2022. Frontiers in cardiovascular medicine, 9 p. 961579. Peer-reviewed.
 
Travailleuses du sexe et accès aux soins
Gloor Élodie, Meystre-Agustoni Giovanna, Ansermet Pagot Anne, Vaucher Paul, Durieux-Paillard Sophie, Bodenmann Patrick, Cavassini Matthias, 2022. pp. 317-326 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 2.5, RMS éditions / Médecine et Hygiène.
 
Vaccination des requérants d’asile dans le canton de Vaud
De Vallière Serge, Landry Pierre, Masserey Éric, Genton Blaise, 2022. pp. 541-547 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 3.9, RMS éditions / Médecine et Hygiène.
Value-added effects of using aromatic plants in foods and human therapy
Taban BM, Stavropoulou E., Winkelströter LK, Bezirtoglou E., 2022. Food Science and Technology, 42 pp. 1-20.
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2021/12/22. Microbiology spectrum, 9 (3) pp. e0139521. Peer-reviewed.
 
A 31-Year-Old Patient Living With Human Immunodeficiency Virus With Thyroiditis and Multiple Intrathoracic Lesions.
Filippidis P., Barras J.L., Cavassini M., Kritikos A., 2021/12/16. Clinical infectious diseases, 73 (12) pp. 2361-2364. Peer-reviewed.
Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland.
Stampf S., Mueller N.J., van Delden C., Pascual M., Manuel O., Banz V., Binet I., De Geest S., Bochud P.Y., Leichtle A. et al., 2021/12/15. BMJ open, 11 (12) pp. e051176. Peer-reviewed.
Diagnostic et prise en charge de l’ostéomyélite chronique des os longs chez l’adulte [Diagnosis and management of chronic osteomyelitis of long bones in adults]
Gilliéron P., Boillat-Blanco N., Nicod Lalonde M., Becce F., Omoumi P., Prior J.O., Borens O., Steinmetz S., 2021/12/15. Revue medicale suisse, 17 (763) pp. 2194-2200. Peer-reviewed.
 
Multicenter Technical Validation of 30 Rapid Antigen Tests for the Detection of SARS-CoV-2 (VALIDATE).
Greub G., Caruana G., Schweitzer M., Imperiali M., Muigg V., Risch M., Croxatto A., Opota O., Heller S., Albertos Torres D. et al., 2021/12/15. Microorganisms, 9 (12) p. 2589. Peer-reviewed.
 
Un cas rare de péritonite de dialyse à Mycobacterium fortuitum
Bedulli Michele, Schwotzer Nora, Halabi George, Jaton Katia, Prodhom Guy, Kritikos Antonios, 2021/12/07. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
Burwick R.M., Yawetz S., Stephenson K.E., Collier A.Y., Sen P., Blackburn B.G., Kojic E.M., Hirshberg A., Suarez J.F., Sobieszczyk M.E. et al., 2021/12/06. Clinical infectious diseases, 73 (11) pp. e3996-e4004. Peer-reviewed.
Lung Ultrasonography for Risk Stratification in Patients with Coronavirus Disease 2019 (COVID-19): A Prospective Observational Cohort Study.
Brahier T., Meuwly J.Y., Pantet O., Brochu Vez M.J., Gerhard Donnet H., Hartley M.A., Hugli O., Boillat-Blanco N., 2021/12/06. Clinical infectious diseases, 73 (11) pp. e4189-e4196. Peer-reviewed.
 
Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience.
Kronig I., Masouridi-Levrat S., Chalandon Y., Glampedakis E., Vernaz N., Van Delden C., Neofytos D., 2021/12. Mycopathologia, 186 (6) pp. 775-788. Peer-reviewed.
 
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J., Reigadas E., Vogelzang E.H., Bouza E., Hristea A., Guery B., Krutova M., Norén T., Allerberger F., Coia J.E. et al., 2021/12. Clinical microbiology and infection, 27 Suppl 2 pp. S1-S21. Peer-reviewed.
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
Battistolo J., Glampedakis E., Damonti L., Poissy J., Grandbastien B., Kalbermatter L., Pagani J.L., Eggimann P., Bochud P.Y., Calandra T. et al., 2021/12. Mycoses, 64 (12) pp. 1512-1520. Peer-reviewed.
 
Infective endocarditis, is there a goal beyond antibiotics and surgery?
Guery B., Papadimitriou-Olivgeris M., 2021/12. European journal of internal medicine, 94 pp. 25-26. Peer-reviewed.
Mapping the human genetic architecture of COVID-19.
COVID-19 Host Genetics Initiative, Niemi M.E.K, 2021/12. Nature, 600 (7889) pp. 472-477. Peer-reviewed.
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.
Damas J., Ledergerber B., Nadin I., Tarr P.E., Stoeckle M., Kunze U., Hauser C., Gutbrod K., Calmy A., Assal F. et al., 2021/12/01. AIDS, 35 (15) pp. 2469-2480. Peer-reviewed.
Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
Tau N., Manuel O., Rozen-Zvi B., Shargian L., Yahav D., 2021/12. Clinical microbiology and infection, 27 (12) pp. 1727-1728. Peer-reviewed.
The EHA Research Roadmap: Infections in Hematology.
Cordonnier C., Ljungman P., Cesaro S., Hirsch H.H., Maschmeyer G., von Lilienfeld-Toal M., Vehreschild M., Mikulska M., Emonts M., Gennery A.R. et al., 2021/12. HemaSphere, 5 (12) pp. e662. Peer-reviewed.
 
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
Lamoth F., Lewis R.E., Walsh T.J., Kontoyiannis D.P., 2021/11/22. The Journal of infectious diseases, 224 (10) pp. 1631-1640. Peer-reviewed.
Prise en charge des patients avec Covid long : illustration par des cas cliniques [Practical management of long Covid disease in outpatients: illustration by clinical cases]
Marone Diop I., Kokkinakis I., Wenker Dabiri C., De Vallière S., Cornuz J., Favrat B., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1915-1921. Peer-reviewed.
 
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
Schoepf I.C., Thorball C.W., Ledergerber B., Engel T., Raffenberg M., Kootstra N.A., Reiss P., Hasse B., Marzolini C., Thurnheer C. et al., 2021/11/02. Clinical infectious diseases, 73 (9) pp. 1597-1604. Peer-reviewed.
Healthcare-associated infections and antibiotic use in long-term care residents from two geographical regions in Switzerland.
Héquet D., Kessler S., Rettenmund G., Lemmenmeier E., Qalla-Widmer L., Gardiol C., Münzer T., Schlegel M., Petignat C., Kohler P., 2021/11. The Journal of hospital infection, 117 pp. 172-178. Peer-reviewed.
 
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.
Courlet P., Barbieux C., Sculier D., Wandeler G., Stoeckle M., Bernasconi E., Braun D., Vernazza P., Cavassini M., Marinosci A. et al., 2021/11. British journal of clinical pharmacology, 87 (11) pp. 4455-4460. Peer-reviewed.
 
Transmission of trained immunity and heterologous resistance to infections across generations.
Katzmarski N., Domínguez-Andrés J., Cirovic B., Renieris G., Ciarlo E., Le Roy D., Lepikhov K., Kattler K., Gasparoni G., Händler K. et al., 2021/11. Nature immunology, 22 (11) pp. 1382-1390. Peer-reviewed.
Viral infections in lung transplantation.
Munting A., Manuel O., 2021/11. Journal of thoracic disease, 13 (11) pp. 6673-6694. Peer-reviewed.
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
Speich B., Chammartin F., Smith D., Stoeckle M.P., Amico P., Eichenberger A.L., Hasse B., Schuurmans M.M., Müller T., Tamm M. et al., 2021/10/21. Trials, 22 (1) p. 724. Peer-reviewed.
 
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.
Roth J.A., Radevski G., Marzolini C., Rauch A., Günthard H.F., Kouyos R.D., Fux C.A., Scherrer A.U., Calmy A., Cavassini M. et al., 2021/10/13. The Journal of infectious diseases, 224 (7) pp. 1198-1208. Peer-reviewed.
 
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment.
Pyngottu A., Scherrer A.U., Kouyos R., Huber M., Hirsch H., Perreau M., Yerly S., Calmy A., Cavassini M., Stöckle M. et al., 2021/10/05. Clinical infectious diseases, 73 (7) pp. e2134-e2141. Peer-reviewed.
 
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Deutschmann E., Bucher H.C., Jaeckel S., Gibbons S., McAllister K., Scherrer A.U., Braun D.L., Cavassini M., Hachfeld A., Calmy A. et al., 2021/10/05. Clinical infectious diseases, 73 (7) pp. e2145-e2152. Peer-reviewed.
 
Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIV.
Engel T., Raffenberg M., Schoepf I.C., Kootstra N.A., Reiss P., Thorball C.W., Hasse B., Hirzel C., Wissel K., Roth J.A. et al., 2021/10/05. Clinical infectious diseases, 73 (7) pp. e2070-e2076. Peer-reviewed.
Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study.
Balakrishna S., Salazar-Vizcaya L., Schmidt A.J., Kachalov V., Kusejko K., Thurnheer M.C., Roth J.A., Nicca D., Cavassini M., Battegay M. et al., 2021/10. PLoS computational biology, 17 (10) pp. e1009529. Peer-reviewed.
SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
Giannella M., Pierrotti L.C., Helanterä I., Manuel O., 2021/10. Transplant international, 34 (10) pp. 1776-1788. Peer-reviewed.
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.
Baunwall SMD, Terveer E.M., Dahlerup J.F., Erikstrup C., Arkkila P., Vehreschild M.J., Ianiro G., Gasbarrini A., Sokol H., Kump P.K. et al., 2021/10. The Lancet regional health. Europe, 9 p. 100181. Peer-reviewed.
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.
Adam K.M., Osthoff M., Lamoth F., Conen A., Erard V., Boggian K., Schreiber P.W., Zimmerli S., Bochud P.Y., Neofytos D. et al., 2021/10. Open forum infectious diseases, 8 (10) pp. ofab471. Peer-reviewed.
 
Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
Glampedakis E., Roth R., Masouridi-Levrat S., Chalandon Y., Mamez A.C., Giannotti F., Van Delden C., Neofytos D., 2021/09/28. Journal of fungi, 7 (10) p. 811. Peer-reviewed.
 
Towards Advances in Medicinal Plant Antimicrobial Activity: A Review Study on Challenges and Future Perspectives.
Vaou N., Stavropoulou E., Voidarou C., Tsigalou C., Bezirtzoglou E., 2021/09/27. Microorganisms, 9 (10) p. 2041. Peer-reviewed.
Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial.
Lhopitallier L., Kronenberg A., Meuwly J.Y., Locatelli I., Mueller Y., Senn N., D'Acremont V., Boillat-Blanco N., 2021/09/21. BMJ, 374 pp. n2132. Peer-reviewed.
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Fekkar A., Neofytos D., Nguyen M.H., Clancy C.J., Kontoyiannis D.P., Lamoth F., 2021/09. Clinical microbiology and infection, 27 (9) pp. 1376-1378. Peer-reviewed.
 
In vitro activity of dalbavancin and other anti-staphylococcal agents against infecting isolates of methicillin-resistant coagulase-negative staphylococci.
Plota M., Papadimitriou-Olivgeris M., Kolonitsiou F., Tsiata E., Spiliopoulou I., Assimakopoulos S.F., Marangos M., 2021/09. Journal of medical microbiology, 70 (9) pp. e001419. Peer-reviewed.
Pancreatitis, hypereosinophilia and bilateral pulmonary infiltrates as presentation of acute Q fever.
Cancela Costa A., Chheang C., Thorens O., Lamy O., Prella M., Babaker M., Lamoth F., Greub G., 2021/09. New microbes and new infections, 43 p. 100940. Peer-reviewed.
 
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial.
Mombelli M., Hoschler K., Cavassini M., Pascual M., Manuel O., 2021/09. The Journal of infection, 83 (3) pp. 354-360. Peer-reviewed.
Initial antimicrobial management of sepsis.
Niederman M.S., Baron R.M., Bouadma L., Calandra T., Daneman N., DeWaele J., Kollef M.H., Lipman J., Nair G.B., 2021/08/26. Critical care, 25 (1) p. 307. Peer-reviewed.
 
Pneumocystis jirovecii Pneumonia and Use of mTOR Inhibitors in Kidney Transplantation.
Coussement J., Manuel O., 2021/08/16. Clinical infectious diseases, 73 (4) pp. 752-753. Peer-reviewed.
Brief Report: Representations and Willingness of People Living With HIV in Switzerland to Participate in HIV Cure Trials: The Case of Gene-Modified Cell Therapies.
Gilles I., Lesage S., Barbieux C., Alessandrini M., Jackson-Perry D., Vittoz L., Peytremann-Bridevaux I., Calmy A., 2021/08/15. Journal of acquired immune deficiency syndromes, 87 (5) pp. 1154-1160. Peer-reviewed.
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Perreau M., Suffiotti M., Marques-Vidal P., Wiedemann A., Levy Y., Laouénan C., Ghosn J., Fenwick C., Comte D., Roger T. et al., 2021/08/09. Nature communications, 12 (1) p. 4888. Peer-reviewed.
 
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.
Kovari H., Surial B., Tarr P.E., Cavassini M., Calmy A., Schmid P., Bernasconi E., Rauch A., Wandeler G., Ledergerber B. et al., 2021/08. HIV medicine, 22 (7) pp. 623-628. Peer-reviewed.
COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary.
Manuel O., 2021/08. Clinical microbiology and infection, 27 (8) pp. 1070-1071. Peer-reviewed.
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.
Thorball C.W., Oudot-Mellakh T., Ehsan N., Hammer C., Santoni F.A., Niay J., Costagliola D., Goujard C., Meyer L., Wang S.S. et al., 2021/08/01. Haematologica, 106 (8) pp. 2233-2241. Peer-reviewed.
Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.
Fougère Y., Schwob J.M., Miauton A., Hoegger F., Opota O., Jaton K., Brouillet R., Greub G., Genton B., Gehri M. et al., 2021/08/01. The Pediatric infectious disease journal, 40 (8) pp. e300-e304. Peer-reviewed.
 
Risk factors for isolation of fluconazole and echinocandin non-susceptible Candida species in critically ill patients.
Papadimitriou-Olivgeris M., Spiliopoulou A., Fligou F., Tsiata E., Kolonitsiou F., Nikolopoulou A., Papamichail C., Spiliopoulou I., Marangos M., Christofidou M., 2021/08. Journal of medical microbiology, 70 (8) pp. 1-8. Peer-reviewed.
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Verweij P.E., Brüggemann RJM, Azoulay E., Bassetti M., Blot S., Buil J.B., Calandra T., Chiller T., Clancy C.J., Cornely O.A. et al., 2021/08. Intensive care medicine, 47 (8) pp. 819-834. Peer-reviewed.
 
The future of SARS-CoV-2 vaccines in transplant recipients: To be determined.
Blumberg E.A., Manuel O., Sester M., Ison M.G., 2021/08. American journal of transplantation, 21 (8) pp. 2629-2630. Peer-reviewed.
 
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity.
Manuel O., Avery R.K., 2021/08/01. Current opinion in infectious diseases, 34 (4) pp. 307-313. Peer-reviewed.
Pancreatic stone protein for early mortality prediction in COVID-19 patients.
Van Singer M., Brahier T., Brochu Vez M.J., Gerhard Donnet H., Hugli O., Boillat-Blanco N., 2021/07/29. Critical care, 25 (1) p. 267. Peer-reviewed.
Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.
Berezowska S., Lefort K., Ioannidou K., Ndiaye D.R., Maison D., Petrovas C., Rotman S., Piazzon N., Milowich D., Sala N. et al., 2021/07/28. Diagnostics, 11 (8) p. 1357. Peer-reviewed.
 
Anévrisme mycotique d'une artère coronaire à Staphylococcus aureus
Trippini Corinna, Boillat-Blanco Noemie, Gachoud David, 2021/07/20. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain.
Aruanno M., Gozel S., Mouyna I., Parker J.E., Bachmann D., Flamant P., Coste A.T., Sanglard D., Lamoth F., 2021/07/14. Medical mycology, 59 (8) pp. 763-772. Peer-reviewed.
 
In Vitro Screening Potential Antibacterial Properties of the Greek Oregano Honey against Clinical Isolates of Helicobacter pylori.
Voidarou C.C., Rozos G., Alexopoulos A., Plessas S., Mantzourani I., Stavropoulou E., Tzora A., Bezirtzoglou E., 2021/07/06. Foods, 10 (7) p. 1568. Peer-reviewed.
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Bressin P., Senn L., Grandbastien B., Andre C. et al., 2021/07/05. BMJ open, 11 (7) pp. e049232. Peer-reviewed.
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
Walti L.N., Mugglin C., Sidler D., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N., Berger C., Boggian K. et al., 2021/07. American journal of transplantation, 21 (7) pp. 2532-2542. Peer-reviewed.
Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication.
Parienti J.J., Fournier A.L., Cotte L., Schneider M.P., Etienne M., Unal G., Perré P., Dutheil J.J., Morilland-Lecoq E., Chaillot F. et al., 2021/07. Open forum infectious diseases, 8 (7) pp. ofab316. Peer-reviewed.
Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections.
Caudron de Coquereaumont G., Couchepin J., Perentes J.Y., Krueger T., Lovis A., Rotman S., Lamoth F., 2021/07. Open forum infectious diseases, 8 (7) pp. ofab174. Peer-reviewed.
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.
Courlet P., Guidi M., Alves Saldanha S., Cavassini M., Stoeckle M., Buclin T., Marzolini C., Decosterd L.A., Csajka C., 2021/07. European journal of clinical pharmacology, 77 (7) pp. 979-987. Peer-reviewed.
 
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
Santos G., Locatelli I., Métral M., Berney A., Nadin I., Calmy A., Tarr P., Gutbrod K., Hauser C., Brugger P. et al., 2021/07. International journal of STD & AIDS, 32 (8) pp. 729-739. Peer-reviewed.
The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients.
Caruana G., Lebrun L.L., Aebischer O., Opota O., Urbano L., de Rham M., Marchetti O., Greub G., 2021/07. New microbes and new infections, 42 p. 100899. Peer-reviewed.
Médecine interne hospitalière dans un hôpital régional : enjeux du présent et défis pour le futur.
Marchetti O., Sedda A., Aebischer O., Blondet F., Tusgul S., Doser N., Urbano L., 2021/06/30. Revue medicale suisse, 17 (744-2) pp. 1279-1281. Peer-reviewed.
 
Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men.
Bachmann N., Kusejko K., Nguyen H., Chaudron S.E., Kadelka C., Turk T., Böni J., Perreau M., Klimkait T., Yerly S. et al., 2021/06/15. Clinical infectious diseases, 72 (12) pp. 2175-2183. Peer-reviewed.
 
Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores.
Dietrich L.G., Thorball C.W., Ryom L., Burkhalter F., Hasse B., Thurnheer M.C., Weisser M., Schmid P., Bernasconi E., Darling KEA et al., 2021/06/15. The Journal of infectious diseases, 223 (12) pp. 2145-2153. Peer-reviewed.
A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.
Guery B., Berger P., Gauzit R., Gourdon M., Barbut F., DAFNE study group, Dafne Study Group, Bémer P., Bessède E., Camou F. et al., 2021/06. The Journal of international medical research, 49 (6) p. 3000605211021278. Peer-reviewed.
 
Causes of fever in Tanzanian adults attending outpatient clinics: a prospective cohort study.
Boillat-Blanco N., Mbarack Z., Samaka J., Mlaganile T., Kazimoto T., Mamin A., Genton B., Kaiser L., D'Acremont V., 2021/06. Clinical microbiology and infection, 27 (6) pp. 913.e1-913.e7. Peer-reviewed.
 
Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature.
Hofmann E., Sidler D., Dahdal S., Bittel P., Suter-Riniker F., Manuel O., Walti L.N., Hirzel C., 2021/06. Transplant infectious disease, 23 (3) pp. e13515. Peer-reviewed.
 
Establishment of a French surveillance system of Clostridiodes difficile infection: Comparison of patient's characteristics with other national and European data.
Khanafer N., Hemmendinger A., Guery B., Vachée A., Rogues A.M., Gravet A., Boutoille D., Vanjak D., Barbut F., Vanhems P., 2021/06. Anaerobe, 69 p. 102329. Peer-reviewed.
Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature.
Tschopp J., Perentes J.Y., Beigelman-Aubry C., Berezowska S., Lovis A., Spertini O., Bochud P.Y., Lamoth F., 2021/06. Medical mycology case reports, 32 pp. 68-72. Peer-reviewed.
 
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
Meylan S., Livio F., Foerster M., Genoud P.J., Marguet F., Wuerzner G., CHUV COVID Vaccination Center, 2021/06. Hypertension, 77 (6) pp. e56-e57. Peer-reviewed.
 
Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19.
Peri A.M., Magro B., van den Bogaart L., Dalla Pria A., Giuffrida P., Gianatti A., Fabretti F., Maria Barbui A., Tebaldi A., Rizzi M. et al., 2021/06/01. Transplantation, 105 (6) pp. e65-e67. Peer-reviewed.
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.
Nguyen H., Thorball C.W., Fellay J., Böni J., Yerly S., Perreau M., Hirsch H.H., Kusejko K., Thurnheer M.C., Battegay M. et al., 2021/06/01. eLife, 10. Peer-reviewed.
 
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.
Surial B., Mugglin C., Calmy A., Cavassini M., Günthard H.F., Stöckle M., Bernasconi E., Schmid P., Tarr P.E., Furrer H. et al., 2021/06. Annals of internal medicine, 174 (6) pp. 758-767. Peer-reviewed.
Self-testing for SARS-CoV-2: importance of lay communication.
Coste A.T., Egli A., Greub G., 2021/05/24. Swiss medical weekly, 151 pp. w20526. Peer-reviewed.
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study.
Mombelli M., Lang B.M., Neofytos D., Aubert J.D., Benden C., Berger C., Boggian K., Egli A., Soccal P.M., Kaiser L. et al., 2021/05. American journal of transplantation, 21 (5) pp. 1789-1800. Peer-reviewed.
 
Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock.
Asner S.A., Desgranges F., Schrijver I.T., Calandra T., 2021/05. The Journal of infection, 82 (5) pp. 125-134. Peer-reviewed.
Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
Ives A., Le Roy D., Théroude C., Bernhagen J., Roger T., Calandra T., 2021/05. FASEB journal, 35 (5) pp. e21418. Peer-reviewed.
 
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A., Mohiuddin M., Manuel O., Vrakas G., Maluf D.G., Buhler L.H., Muller Y.D., Pascual M., 2021/05. Xenotransplantation, 28 (3) pp. e12681. Peer-reviewed.
 
Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.
Reichmuth M.L., Chaudron S.E., Bachmann N., Nguyen H., Böni J., Metzner K.J., Perreau M., Klimkait T., Yerly S., Hirsch H.H. et al., 2021/05. HIV medicine, 22 (5) pp. 346-359. Peer-reviewed.
 
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.
Glampedakis E., Cassaing S., Fekkar A., Dannaoui E., Bougnoux M.E., Bretagne S., Neofytos D., Schreiber P.W., Hennequin C., Morio F. et al., 2021/04/26. Clinical infectious diseases, 72 (8) pp. 1379-1385. Peer-reviewed.
 
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.
Glass T.R., Günthard H.F., Calmy A., Bernasconi E., Scherrer A.U., Battegay M., Steffen A., Böni J., Yerly S., Klimkait T. et al., 2021/04/26. Clinical infectious diseases, 72 (8) pp. 1413-1421. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University